Precision diagnosis, breast-conserving surgery, breast reconstruction, and neoadjuvant therapy — integrating surgical oncology with plastic repair to pursue tumor eradication while preserving body form and psychological recovery.
A comprehensive breast cancer center that brings together surgical oncology, plastic surgery, medical oncology, pathology, radiology, imaging, and genetics under one roof.
The Breast Cancer Center at Beijing Arion Cancer Hospital is built on a pioneering philosophy: curing cancer while preserving the patient's body image and quality of life. We integrate surgical oncology with plastic and reconstructive surgery, ensuring that every treatment plan considers not only tumor eradication but also the patient's physical appearance and psychological well-being.
Our center brings together specialists from breast surgery, plastic surgery, medical oncology, pathology, radiology, imaging, and genetics — forming a dedicated MDT core team that follows each patient from diagnosis through long-term follow-up. This real-time, full-term MDT model ensures that treatment decisions are made collaboratively, not in isolation, and that plans are adjusted dynamically as the patient's condition evolves.
From early-stage breast cancer screening to complex locally advanced cases, from genetic risk assessment to survivorship care, our center provides the full spectrum of breast cancer services aligned with international guidelines and UPMC quality standards.
Tumor eradication + body form preservation + psychological recovery
Every breast cancer patient receives a dedicated multidisciplinary team from day one, with real-time coordination across all specialties throughout the entire treatment journey.
Our MDT team jointly reviews imaging, pathology, and genetic test results to establish a precise diagnosis and staging. Breast surgeons, medical oncologists, pathologists, radiologists, and genetic counselors contribute their expertise in a single consensus discussion — eliminating the delays and fragmentation of traditional sequential consultations.
Based on tumor biology, molecular subtype, stage, genetic profile, and the patient's personal preferences, the MDT team develops an individualized treatment plan. Options may include neoadjuvant therapy to shrink tumors before surgery, breast-conserving surgery, breast reconstruction, adjuvant therapy, and targeted or endocrine therapy — all sequenced for optimal outcomes.
Unlike traditional models where treatment plans are set at the start, our MDT team meets regularly to review each patient's response to therapy. If a tumor responds differently than expected to neoadjuvant therapy, or if pathology findings suggest a different approach, the plan is adjusted in real time — with the entire team aligned.
A full spectrum of evidence-based breast cancer treatments, individually tailored and MDT-coordinated.
Advanced imaging (3.0T MRI, digital mammography, breast ultrasound), core needle biopsy, molecular subtyping, and BRCA1/BRCA2 genetic testing for hereditary risk assessment.
Lumpectomy with sentinel lymph node biopsy — removing the tumor while preserving the breast. Oncoplastic techniques ensure aesthetic outcomes without compromising cancer clearance.
Immediate and delayed reconstruction options including implant-based and autologous tissue flap reconstruction. Plastic surgeons work alongside breast surgeons for optimal aesthetic results.
Chemotherapy, targeted therapy, or endocrine therapy delivered before surgery to shrink tumors, enable breast-conserving surgery, and assess treatment response for further planning.
HER2-targeted therapy (trastuzumab, pertuzumab), CDK4/6 inhibitors, PARP inhibitors for BRCA mutations, and endocrine therapy for hormone receptor-positive breast cancer.
Immune checkpoint inhibitors for triple-negative breast cancer, combined with chemotherapy in neoadjuvant and metastatic settings, guided by PD-L1 expression testing.
Our Breast Cancer Center is led by renowned oncologists from China's top cancer institutions, each bringing decades of specialized experience to the MDT team.
A distinguished breast cancer medical oncologist from Peking University Cancer Hospital, Dr. Song specializes in the systemic treatment of breast cancer. With extensive clinical experience in chemotherapy, endocrine therapy, targeted therapy, and immunotherapy, he develops personalized treatment strategies for all breast cancer subtypes and stages.
From the Breast Cancer Prevention Center at Peking University Cancer Hospital, Dr. Li is a leading breast surgical oncologist. He is renowned for his expertise in breast-conserving surgery and breast shaping techniques, as well as sentinel lymph node biopsy — helping patients achieve cancer-free outcomes while preserving the natural appearance of the breast.
A seasoned medical oncologist from Beijing Fuxing Hospital, Dr. Pan brings broad expertise in breast cancer, gastrointestinal tumors, and lung cancer. His particular strength lies in MDT-based treatment of advanced and complex cases, where multidisciplinary coordination is essential for optimal outcomes in patients with metastatic or refractory disease.
From the Breast Center of the PLA General Hospital 7th Medical Center, Dr. Wang has extensive experience in early breast cancer screening, image-guided biopsy, and minimally invasive surgery. She provides comprehensive treatment management with a focus on early detection and intervention — the foundation of successful breast cancer outcomes.
An attending physician at Arion Cancer Hospital's Breast Center, Dr. Wang treats breast cancer and gastrointestinal tumors with a comprehensive, patient-centered approach. He also specializes in palliative care, ensuring that patients with advanced disease receive compassionate symptom management and quality-of-life support alongside their cancer treatment.
Our unique advantages make us a leading destination for international breast cancer patients seeking world-class care in China.
Our clinical protocols and quality standards are aligned with UPMC (University of Pittsburgh Medical Center), bringing American cancer care excellence to Beijing. Remote consultations with UPMC specialists are available for complex cases.
By integrating breast surgery with plastic and reconstructive surgery, we offer breast-conserving and reconstruction options that prioritize both cancer eradication and aesthetic outcomes — helping patients recover physically and psychologically.
Every international patient is assigned a personal Case Manager who coordinates all appointments, communicates with the MDT team, arranges interpretation, and provides continuous support from first contact through long-term follow-up.